Instability in Pentanucleotide Markers in a Subset of Microsatellite Instability-High Colorectal Cancer
Authors:
- Ahmet YilmazAYAhmet Yilmaz
- Wendy L. FrankelWFWendy L. Frankel
- Benjamin J. SwansonBSBenjamin J. Swanson
- Kristin MillerKMKristin Miller
- Jason BacherJBJason Bacher
- Christopher BigleyCBChristopher Bigley
- Lori NelsenLNLori Nelsen
- Matthew F. KaladyMKMatthew F. Kalady
- Joshua F. ColemanJCJoshua F. Coleman
- Rachel PearlmanRPRachel Pearlman
- Heather HampelHHHeather Hampel
Open Access
- 2 April 2026
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 33 (4) , 205
Abstract
Microsatellite instability (MSI) testing is frequently used to screen patients for the early detection of Lynch syndrome, the most common hereditary colorectal cancer syndrome. MSI testing compares microsatellite repeat lengths in tumor DNA with those in matched normal tissue from the same patient. Therefore, precise sample identification is critical for obtaining reliable test results. The Penta-C and Penta-D pentanucleotide markers are widely used for sample identification in MSI testing. We investigated instability, defined as allelic mismatches or shifts, discordant fragment sizes, or the appearance of alleles in tumor DNA that were absent in the corresponding normal DNA, in the Penta-C and Penta-D loci across 2609 paired colorectal tumor and matched normal tissue or blood DNA samples. The allele sizes of both markers did not match in 0.3% of microsatellite-stable (MSS) and 12.3% of microsatellite instability-high (MSI-H) patients (p < 0.001, difference in proportions, 12.0% (95% CI, 8.9–15.1%)). Non-matching allele sizes in 12.3% of the MSI-H tumors suggest that other repeat markers may also be unstable and not suitable for sample identification in these tumors.Keywords
Funding Information
- Pelotonia
This publication has 36 references indexed in Scilit:
- Outcomes Following Immune Checkpoint Inhibitor Treatment of Patients With Microsatellite Instability-High CancersJAMA Oncology, 2020
- JSCO—ESMO—ASCO—JSMO—TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusionsAnnals of Oncology, 2020
- Clinical Performance of the Idylla MSI Test for a Rapid Assessment of the DNA Microsatellite Status in Human Colorectal CancerThe Journal of Molecular Diagnostics, 2020
- Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal CancerJAMA Oncology, 2018
- DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panelLung Cancer, 2017
- Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal CancerJAMA Oncology, 2017
- Differences in Microsatellite Instability Profiles between Endometrioid and Colorectal CancersThe Journal of Molecular Diagnostics, 2017
- Regional Bias of Intratumoral Genetic Heterogeneity of Nucleotide Repeats in Colon Cancers with Microsatellite InstabilityPathology and Oncology Research, 2014
- Use of mononucleotide repeat markers for detection of microsatellite instability in mouse tumorsMolecular Carcinogenesis, 2005
- Cancer Risk in Hereditary Nonpolyposis Colorectal Cancer Syndrome: Later Age of OnsetGastroenterology, 2005